Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke

類似資料

• The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
  著者:: Vladimer Darsalia, 等
  出版事項: (2018-02-01)
• The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
  著者:: Darsalia, Vladimer, 等
  出版事項: (2018)
• The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
  著者:: Darsalia, Vladimer, 等
  出版事項: (2013)
• Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke
  著者:: Darsalia, Vladimer, 等
  出版事項: (2019)
• The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway
  著者:: Chiazza, Fausto, 等
  出版事項: (2018)